MedPath logo

CLARITYN SYRUP 5 mg/5 ml

General Sale List
Drug type: Therapeutic
ATC code: R06AX13
Dosage form: SYRUP
Route of administration: ORAL
Active ingredient: LORATADINE (MICRONIZED); LORATADINE (MICRONIZED)

1. What Clarityn®/Clarityne® are and what they are used for

Clarityn®/Clarityne® belongs to a class of medicines known as antihistamines. Antihistamines help to reduce allergic symptoms by preventing the effects of a substance called histamine, which is produced in the body.

Clarityn®/Clarityne® relieves symptoms associated with allergic rhinitis, such as sneezing, runny or itchy nose and burning or itchy eyes.

Clarityn®/Clarityne® may also be used to help relieve symptoms of urticaria (itching, redness and number and size of hives).

Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep.

2. Before you take Clarityn®/Clarityne®

Do not take Clarityn®/Clarityne®

If you are allergic (hypersensitive) to loratadine or any of its other ingredients.

3. How to take Clarityn®/Clarityne®

Clarityn Dosage Table 1

Clarityn Dosage Table 2

Do not give this medicine to children under 2 years of age.

If you have severe liver problems, your pharmacist or doctor may advise you to take one tablet once every other day with a glass of water, with or without food.

If you take more than you should

Take Clarityn®/Clarityne® only as it is described in the directions. No serious problems are expected with accidental overdose. However, if you take more than you were told to, contact your pharmacist or doctor immediately.

Sleepiness, rapid heartbeat and headache have been reported with overdoses of Clarityn®/Clarityne®.

If you forget to take a dose

If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.

If you stop taking your Clarityn®/Clarityne®

If you have any further questions on the use of this product, ask your pharmacist or doctor.

Registrant
BAYER (SOUTH EAST ASIA) PTE LTD
Approval Date
1995-02-02
Approval Number
SIN08022P
Manufacturer
PT Merck Sharp Dohme Pharma Tbk
Licence Holder
BAYER (SOUTH EAST ASIA) PTE LTD